Portuguese Registry on Acute Coronary Syndromes
ProACS
1 other identifier
observational
50,000
1 country
1
Brief Summary
The purpose of this Registry is creating a database management that allows continuous monitoring characteristics, evolution, prognostic indicators and management of patients with ACS admitted in Portuguese Hospitals, and identify the appropriateness of clinical practice recommendations for diagnosis and treatment of ACS and monitor its evolution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2002
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2002
CompletedFirst Submitted
Initial submission to the registry
July 13, 2012
CompletedFirst Posted
Study publicly available on registry
July 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedOctober 10, 2016
October 1, 2016
15.9 years
July 13, 2012
October 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital mortality in patients admitted for acute coronary syndrome
Evaluation of hospital mortality rate of patients admitted for acute coronary syndrome
Hospital dead in patients admitted with acute coronary syndrome
Secondary Outcomes (1)
major adverse cardiac events (MACE)
In-hospital MACE in patients admitted for acute coronary syndrome
Other Outcomes (1)
Major bleeding
In hospital major bleeding
Eligibility Criteria
All adult patients with Acute Coronary Syndrome (ACS) with \<48 hours of evolution, admitted to Portuguese Hospitals.
You may qualify if:
- presence of angina at rest last 48 hours, with: 1) ischemic electrocardiographic changes - ST-segment deviations or negative T waves, and / or 2) elevation of biomarker(cardiac troponin and CK-MB) above the reference value.
You may not qualify if:
- patients with MI after revascularization procedures (EAM type 4 and 5) and MI type 2 (classification according to the redefinition of Myocardial Infarction, 2007 the Joint ESC / ACCF / AHA / WHF Task Force).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CNCDC
Coimbra, Coimbra District, 3000-306, Portugal
Related Links
Biospecimen
no samples retained
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jorge V Mimoso, MD
Portuguese Society of Cardiology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2012
First Posted
July 17, 2012
Study Start
January 1, 2002
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
October 10, 2016
Record last verified: 2016-10